tirzepatide sydney MOUNJARO® (tirzepatide) soon to be available for Australian adults with type 2 diabetes Zepbound Tirzepatide Injection 2.5 mg/0.5

Clinical trials indicate that the medication is safe for extended use, with most patients experiencing mild to moderate gastrointestinal side effects such as nausea, vomiting, diarrhea, or constipation

Unraveling the molecular underpinnings dictating the immunogenicity of cell ferroptosis warrants further elucidation

G.MurrayM

Before GLP based therapy became available, losing 10 to 20 percent of body weight through medication alone was extremely rare

These data provide preliminary evidence that GLP-1RAs could act through peripheral mechanisms to suppress alcohol intake, the authors wrote in their paper, published Wednesday in Scientific Reports

A small trial compared the serum/blood levels of metabolites in arterial and jugular venous blood to indirectly assess metabolite uptake into the brain [50]